Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
15.84 USD | +1.15% | -2.22% | +24.24% |
May. 07 | Curis, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 07 | Transcript : Curis, Inc., Q1 2024 Earnings Call, May 07, 2024 |
Chart calendar Curis, Inc.
Upcoming events on Curis, Inc.
Past events on Curis, Inc.
2024-05-07 08:30 am | Q1 2024 Earnings Call |
2024-05-07 08:00 am | Q1 2024 Earnings Release |
2024-04-08 12:45 pm | Needham Healthcare Conference |
2024-02-08 08:30 am | Q4 2023 Earnings Call |
2024-02-08 08:00 am | Q4 2023 Earnings Release |
2023-12-11 09:00 pm | American Society of Hematology Meeting - Abstract No - 4497 |
2023-12-10 09:00 pm | American Society of Hematology Meeting - Abstract No - 3143 |
2023-12-10 09:00 pm | American Society of Hematology Meeting - Abstract No - 2924 |
2023-11-02 08:30 am | Q3 2023 Earnings Call |
2023-11-02 08:00 am | Q3 2023 Earnings Release |
2023-09-28 | Reverse Split: 1 of 20 |
2023-09-27 09:10 am | Cantor Global Healthcare Conference |
2023-09-26 10:00 am | Extraordinary Shareholders Meeting |
2023-09-22 09:00 am | IRAK4 Symposium |
2023-09-12 08:30 am | H.C. Wainwright Global Investment Conference |
2023-08-03 04:30 pm | Q2 2023 Earnings Call |
2023-08-03 04:01 pm | Q2 2023 Earnings Release |
2023-05-23 10:00 am | Annual General Meeting |
2023-05-04 04:30 pm | Q1 2023 Earnings Call |
2023-05-04 04:01 pm | Q1 2023 Earnings Release |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 | 10,8 10,6 1.96% | 10,6 10,7 -0.25% | 10,2 10,4 -2.56% | 10,0 10,3 -2.9% | 8,16 |
EBITDA Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | -41,9 -40,0 -4.77% | -52,8 -54,0 2.25% | 0,00 0,00 - | -48,8 |
EBIT Million USD | Released Forecast Spread | 0,00 | -24,9 -23,8 -4.58% | -42,1 -40,4 -4.21% | -53,0 -54,0 1.75% | -48,3 -48,1 -0.49% | -49,6 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -29,9 -28,9 -3.37% | -45,4 -43,8 -3.77% | -56,7 -57,2 0.96% | -47,4 -48,7 2.6% | -47,9 |
Net income Million USD | Released Forecast Spread | -32,1 | -29,9 -28,8 -3.81% | -45,4 -43,8 -3.77% | -56,7 -57,6 1.55% | -47,4 -48,7 2.66% | -47,9 |
EPS USD | Released Forecast Spread | -19,4 | -12,2 -11,9 -2.23% | -10,0 -9,56 -4.6% | -12,2 -12,4 1.61% | -8,96 -6,85 -30.76% | -6,18 |
Announcement Date | 19/03/20 | 16/03/21 | 24/02/22 | 13/03/23 | 08/02/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 2,06 2,55 -19.31% | 2,39 2,72 -12.09% | 2,83 3,16 -10.56% | 2,89 3,26 -11.35% | 2,30 2,59 -11.22% | 2,20 2,51 -12.63% | 2,83 2,63 7.92% | 2,70 3,08 -12.58% | 2,09 2,00 4.07% | 1,84 | 2,12 | 2,15 | 2,55 | 2,60 |
EBITDA Million USD | Released Forecast Spread | -15,1 -14,6 -3.4% | -15,0 -15,0 -0.05% | -12,5 -15,0 16.37% | -10,1 -12,0 15.6% | -11,6 -9,94 -16.33% | -12,1 -11,6 -4.45% | -12,3 -11,6 -6.44% | -12,4 -12,4 -0.36% | -12,4 | -11,9 | -12,1 | -13,2 | -13,4 | |
EBIT Million USD | Released Forecast Spread | -15,1 -13,7 -10.66% | -15,1 -14,5 -3.76% | -12,6 -14,5 13.2% | -10,2 -11,4 10.05% | -11,6 -9,51 -22.33% | -12,1 -11,1 -9.42% | -12,4 -11,5 -7.99% | -12,2 -12,3 0.67% | -12,5 -12,7 1.56% | -12,6 | -12,3 | -12,3 | -12,6 | -13,3 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -16,1 -14,7 -9.36% | -15,9 -15,2 -4.92% | -13,3 -15,4 13.89% | -11,3 -12,0 5.54% | -11,6 -10,5 -10.24% | -12,0 -11,9 -0.46% | -12,2 -12,1 -0.38% | -11,7 -12,1 3.32% | -11,9 -12,6 5.51% | -12,5 | -12,0 | -12,0 | -12,3 | -13,2 |
Net income Million USD | Released Forecast Spread | -16,1 -14,7 -9.37% | -15,9 -15,3 -4.04% | -13,3 -15,5 14.27% | -11,3 -12,3 7.92% | -11,6 -10,5 -10.15% | -12,0 -11,8 -1.55% | -12,2 -12,1 -0.75% | -11,7 -12,3 4.99% | -11,9 -12,6 5.72% | -12,4 | -12,0 | -12,0 | -12,3 | -13,2 |
EPS USD | Released Forecast Spread | -3,60 -3,20 -12.5% | -3,40 -3,30 -3.03% | -2,80 -3,40 17.65% | -2,40 -2,55 5.88% | -2,40 -2,15 -11.63% | -2,40 -2,35 -2.13% | -2,13 -2,36 9.65% | -2,03 -2,12 4.25% | -2,05 -2,05 0% | -1,87 | -1,66 | -1,44 | -1,29 | -1,37 |
Announcement Date | 05/05/22 | 04/08/22 | 09/11/22 | 13/03/23 | 04/05/23 | 03/08/23 | 02/11/23 | 08/02/24 | 07/05/24 | - | - | - | - | - |
2024-05-14 | GNI GROUP LTD.: Q1 2024 Earnings Release |
2024-05-15 | REPLIMUNE GROUP, INC.: Q4 2024 Earnings Release (Projected) |
2024-05-17 02:00 am | BIOARCTIC AB: Q1 2024 Earnings Release |
2024-05-20 | ALVOTECH: Q1 2024 Earnings Release |
2024-05-21 | CUREVAC N.V.: Q1 2024 Earnings Release (Projected) |
2024-05-21 | EXSCIENTIA PLC: Q1 2024 Earnings Release (Projected) |
2024-05-21 | EVOTEC SE: Q1 2024 Earnings Release |
2024-06-30 | IMMUNOVANT, INC.: Q4 2024 Earnings Release (Projected) |
2024-07-15 01:45 am | ADDLIFE AB: Q2 2024 Earnings Release |
2024-07-21 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
Past sector events for Curis, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CRIS Stock
- Calendar Curis, Inc.